Use of medical cannabis increased substantially in Denmark during 2025, while the Danish Medicines Agency reported three suspected adverse-reaction cases and identified no new or changed safety signals. The Agency received three reports relating to cannabis products supplied under Denmark’s medical cannabis pilot programme during the year. Two concerned suspected serious adverse reactions and one […]
The post Danish medical cannabis use rises as regulator reports no new safety signals appeared first on Pharmafile.